BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 487808)

  • 21. Postpartum IUDS: keys for success.
    O'Hanley K; Huber DH
    Contraception; 1992 Apr; 45(4):351-61. PubMed ID: 1516367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
    Nilsson CG; Allonen H; Diaz J; Luukkainen T
    Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. One-year clinical experience with FlexiGard.
    Batar I
    Contraception; 1992 Oct; 46(4):307-12. PubMed ID: 1486769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Five years' experience with levonorgestrel-releasing IUDs.
    Luukkainen T; Allonen H; Haukkamaa M; Lähteenmäki P; Nilsson CG; Toivonen J
    Contraception; 1986 Feb; 33(2):139-48. PubMed ID: 3084167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immediate postpartum insertion of a copper-wired intrauterine contraceptive device, the MLCu250.
    Thiery M; Van Der Pas H; Delbeke L; Van Kets H
    Br J Obstet Gynaecol; 1979 Aug; 86(8):654-8. PubMed ID: 497136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of a progesterone-releasing intrauterine contraceptive device on endometrial blood vessels: a morphometric study.
    Shaw ST; Macaulay LK; Aznar R; González-Angulo A; Roy S
    Am J Obstet Gynecol; 1981 Dec; 141(7):821-7. PubMed ID: 7315908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of the use of intrauterine devices in nulliparous women.
    Graham S; Simcock BW
    Contraception; 1982 Oct; 26(4):323-46. PubMed ID: 6759026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of three different models of the copper T intrauterine contraceptive device.
    Roy S; Casagrande J; Cooper DL; Mishell DR
    Am J Obstet Gynecol; 1979 Jul; 134(5):568-74. PubMed ID: 453297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Contraception with the intrauterine pessary Progestasert].
    Schweppe KW; Tenhaeff D; Rache D
    Fortschr Med; 1978 Sep; 96(33):1685-90. PubMed ID: 700553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrauterine contraception with Nova-T and copper-T-200 during three years.
    Nygren KG; Nielsen NC; Pyörälä T; Allonen H; Luukkainen T
    Contraception; 1981 Nov; 24(5):529-42. PubMed ID: 7032839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Twelve-month comparative multicenter study of the TCu 380A and ML 250 intrauterine devices in Bangkok, Thailand.
    Reinprayoon D; Gilmore C; Farr G; Amatya R
    Contraception; 1998 Oct; 58(4):201-6. PubMed ID: 9865999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selected events following insertion of the Progestasert system.
    Gibor Y; Mitchell C
    Contraception; 1980 May; 21(5):491-503. PubMed ID: 7428359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two-year rates for Nova T and Copper T in a comparative study.
    Allonen H; Luukkainen T; Nielsen NC; Nygren KG; Pyörälä T
    Contraception; 1980 Apr; 21(4):321-34. PubMed ID: 6993095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors affecting intrauterine contraceptive device performance. I. Endometrial cavity length.
    Hasson HM; Berger GS; Edelman DA
    Am J Obstet Gynecol; 1976 Dec; 126(8):973-81. PubMed ID: 998687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levonorgestrel plasma concentrations and hormone profiles after insertion and after one year of treatment with a levonorgestrel-IUD.
    Nilsson CG; Lähteenmäki P; Luukkainen T
    Contraception; 1980 Mar; 21(3):225-33. PubMed ID: 6771090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can intrauterine device removals for bleeding or pain be predicted at a one-month follow-up visit? A multivariate analysis.
    Stanback J; Grimes D
    Contraception; 1998 Dec; 58(6):357-60. PubMed ID: 10095972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effectiveness research of medicated γ intrauterine device and medicated genefix intrauterine device inserted immediately after abortion].
    Wang K; Cheng Y; Yang H; Tang YH; Jiang J; Ji F; Li LB; Wu SC
    Zhonghua Fu Chan Ke Za Zhi; 2016 Mar; 51(3):198-203. PubMed ID: 27030499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison between two IUDs: Progestasert and CuT 200.
    Larsen S; Hansen MK; Jacobsen JC; Ladehoff P; Sorensen T; Westergaard JG
    Contracept Deliv Syst; 1981 Oct; 2(4):281-6. PubMed ID: 12336988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Copper T 220C: a new long-acting copper intrauterine contraceptive device.
    Cooper DL; Millen AK; Mishell DR
    Am J Obstet Gynecol; 1976 Jan; 124(2):121-4. PubMed ID: 1247047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.